2025 annual financial data
Kalaris Therapeutics 2025 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -46,152,000 USD and net income was -43,438,000 USD.
Operating cash flow was -42,976,000 USD.
Get free Kalaris Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -46,152,000 USD
- Net income
- -43,438,000 USD
- Operating cash flow
- -42,976,000 USD